Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : PYNG Technologies -- Ignore unavailable to you. Want to Upgrade?

To: LOR who wrote (3590)	3/31/1999 1:08:00 PM
From: Ross	Read Replies (1) \| Respond to of 8117

NEWS RELEASE MARCH 31, 1999 Pyng Technologies Update VANCOUVER, BRITISH COLUMBIA--Michael W. Jacobs, President, Pyng Technologies Corp. and Pyng Medical Corp. is pleased to announce the following Pyng Medical Corp. personnel have had the opportunity to train 23 Instructors at the Joint Operations Medical Training Center, School and US Army JFK Special Warfare Center. According to the Director, Medical Research and Development, United States Army Special Operations Command, Pyng Medical Corp's training procedures and professional approach to delivering instruction on the F.A.S.T 1 System for Adult Intraosseous Infusion during the time frame allotted was well received by the JFK Instructors. The training session introduced the F.A.S.T 1 System, provided "hands on" use of the System in cadavers, as well as provide the Instructors at JFK the opportunity to discuss, in detail, the benefits of Intraosseous Infusion in a battlefield environment utilizing the F.A.S.T 1 System. The US Army JFK Special Warfare School and Center is the lead center for training Special Operations Command medics throughout the US Military Forces. Pyng Medical Corp.also has had the opportunity to present the F.A.S.T 1 System at the EMS Today Conference in Denver, March 24 through 27th 1999. Several opportunities were presented to Pyng Medical for the distribution of the F.A.S.T 1 System across America. Michael Jacobs, President, who was present at the conference, has agreed to start initial negotiations with several medical product distributors that meet Pyng Medical Corp.criteria for proper exposure to the pre-hospital and emergency hospital market place in their regional zones. Such criterion includes sales staff trained in emergency medical procedures and who concentrate their sales efforts in the emergency hospital and pre-hospital medical market place. The distributors demonstrated abilities to work closely with appropriate contacts in the emergency market place as well as having the abilities to warehouse, stock, and ship in a timely manner to service the anticipated demand are important issues to Pyng Medical Corp. Mr. Jacobs also had the opportunity to meet with Operations Managers and Supervisors of American Medical Response, America's largest ambulance service as well as the Deputy Commander, United States Public Health Service, National Medical Response Team. Pyng Medical Corp. is now concentrating all efforts to bring the F.A.S.T 1 System to market as we gear up for mass production. Field trials on the F.A.S.T 1 have provided a great deal of input for product improvements as well as provide proof positive as to the effectiveness of the F.A.S.T 1 System for Adult Intraosseous Infusion to gain vascular access in emergency situations when conventional I.V. methods fail. -30- FOR FURTHER INFORMATION PLEASE CONTACT: Pyng Technologies Corp. Michael W. Jacobs 1-800-349-7964 Website: www.pyng.com The VSE has neither reviewed nor approved of the contents of this news release.